“It’s great to educate Georgia residents on such a serious topic,” Dr. Bowen said.
During the broadcast, which aired June 2, Dr. Bowen discussed the American Cancer Society study recently presented at the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting. The study involved administrative claims, medical charts, and other data of more than 3,000 BlueCross and BlueShield of Georgia members diagnosed with breast cancer between January 2000 and August 2005.
The study showed that the health insurance companies are paying out more for the treatment of African-American women than white women. According to the study, a higher proportion of white women get quality care when compared to the number of African-American women who get adequete care.
An ASCO member, Dr. Bowen’s special interests include management of breast cancer and chemoprevention for women at a high risk.
Dr. Bowen practices at GCS’s Alpharetta and Northside offices.
Georgia Cancer Specialists is the largest private oncology/hematology practice in the Southeast and a leader in advanced cancer treatment and research. The practice offers community-based medical oncology and hematology services and is the first private oncology practice to also provide a full range of support services for patients in Georgia, including nutritional counseling, pain management, wellness counseling, and home health coordination. The GCS research department, whose focus is bringing targeted cancer therapy to communities, is the first in Georgia to offer Phase I clinical trials, the most novel cancer therapies available. GCS has 32 offices, 41 doctors, and over 540 support staff members located in Metro Atlanta and North and Central Georgia, and provides care through approximately 160,000 annual patient visits.